What is NDC 83634-655?

83634-655 is the product NDC for Cisatracurium Besylate, Cisatracurium besylate 10 mg/mL injection, solution, listed with the FDA by Avenacy, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.

Avenacy, LLC, NDC labeler code 83634. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.

What other NDCs exist for Cisatracurium Besylate?

34 other product NDCs are listed under this name.

Is there a related HCPCS / J-code?

Not in Med-Code's curated HCPCS directory.

Cisatracurium Besylate NDC 83634-655

NDC codes

FDA NDC Directory

Product NDC (as listed)83634-655Labeler and product segments. Claims need a package NDC.

Product NDC at billing width83634-0655Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
83634-655-20	8363406552083634065520	10 VIAL, SINGLE-DOSE in 1 CARTON (83634-655-20) / 20 mL in 1 VIAL, SINGLE-DOSE (83634-655-41)Marketed from Aug 15, 2026

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Cisatracurium Besylate
Generic name (nonproprietary): cisatracurium besylate
Active ingredients: Cisatracurium besylate — 10 mg/mL
Dosage form: Injection, Solution
Route: Intravenous
Labeler: Avenacy, LLCNDC labeler code 83634
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 216539
Marketing start: Aug 15, 2026
Listing expires: Dec 31, 2027
Other FDA classes: Neuromuscular Nondepolarizing Blockade (Physiologic effect)
Identifiers: Product ID 83634-655_53f69aa3-898e-476d-b18c-573487371a10SPL ID 53f69aa3-898e-476d-b18c-573487371a10SPL set ID 1c6a8b98-deac-4e25-b4a0-5d0af5090281RxCUI 199212UNII 80YS8O1MBS
Pharmacologic class: Nondepolarizing Neuromuscular Blocker

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N483634065520 followed by a unit qualifier and the quantity

Package 83634-0655-20. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Jun 30, 2026.

Indications (excerpt from the label)

Cisatracurium Besylate Injection is indicated: as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric patients 1 month to 12 years of age to provide skeletal muscle relaxation in adults during surgical procedures or during mechanical ventilation in the ICU to provide skeletal muscle relaxation during surgical procedures via infusion in pediatric patients 2 years and older Cisatracurium Besylate Injection is a nondepolarizing neuromuscular blocker indicated: as an adjunct to general anesthesia to facilitate tracheal intubation in adults and in pediatric patients 1 month to 12 years of age ( 1 ) to provide skeletal muscle relaxation during surgery in a…

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

About NDC 83634-655

What is NDC 83634-655?: 83634-655 is the product NDC for Cisatracurium Besylate, Cisatracurium besylate 10 mg/mL injection, solution, listed with the FDA by Avenacy, LLC. It has 1 package NDC, shown above in 10- and 11-digit form.
What drug is associated with this NDC?: Cisatracurium Besylate.
What is the active ingredient?: Cisatracurium besylate.
Who is the labeler?: Avenacy, LLC, NDC labeler code 83634. The labeler is the company responsible for the label; it may be the manufacturer, a repackager or a distributor.
What other NDCs exist for Cisatracurium Besylate?: 34 other product NDCs are listed under this name. See all Cisatracurium Besylate NDCs.
Is there a related HCPCS / J-code?: Not in Med-Code's curated HCPCS directory. See Billing references above.

Other finished products listed under the same name: strengths, forms and labelers.

Other Cisatracurium Besylate NDCs
Product	Strength	Form · route	Labeler	Product NDC	Package NDCs (11-digit)
Cisatracurium Besylate	Cisatracurium besylate 10 mg/mL	InjectionIntravenous	Camber Pharmaceuticals Inc.	31722-312	31722-0312-10
Cisatracurium Besylate	Cisatracurium besylate 2 mg/mL	InjectionIntravenous	Camber Pharmaceuticals Inc.	31722-313	31722-0313-10
Cisatracurium Besylate	Cisatracurium besylate 2 mg/mL	InjectionIntravenous	Camber Pharmaceuticals Inc.	31722-314	31722-0314-10
Cisatracurium besylate	Cisatracurium besylate 2 mg/mL	InjectionIntravenous	Gland Pharma Limited	68083-486	68083-0486-01
Cisatracurium besylate	Cisatracurium besylate 10 mg/mL	InjectionIntravenous	Gland Pharma Limited	68083-487	68083-0487-01
Cisatracurium besylate	Cisatracurium besylate 2 mg/mL	InjectionIntravenous	Gland Pharma Limited	68083-488	68083-0488-01
Cisatracurium Besylate	Cisatracurium besylate 10 mg/mL	InjectionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9160	00143-9160-10
Cisatracurium Besylate	Cisatracurium besylate 2 mg/mL	InjectionIntravenous	Hikma Pharmaceuticals USA Inc.	0143-9397	00143-9397-10
Cisatracurium besylate	Cisatracurium besylate 2 mg/mL	InjectionIntravenous	Caplin Steriles Limited	65145-135	65145-0135-0165145-0135-10
Cisatracurium besylate	Cisatracurium besylate 2 mg/mL	InjectionIntravenous	Caplin Steriles Limited	65145-136	65145-0136-0165145-0136-10

All 35 Cisatracurium Besylate NDCs

Other NDCs under ANDA 216539

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 216539
Product	Strength	Form · route	Labeler	Product NDC
Cisatracurium besylate	Cisatracurium besylate 2 mg/mL	InjectionIntravenous	Slate Run Pharmaceuticals, LLC	70436-112
Cisatracurium besylate	Cisatracurium besylate 10 mg/mL	InjectionIntravenous	Slate Run Pharmaceuticals, LLC	70436-114